The S&P/ASX 200 Index (ASX: XJO) ascended 1% last week and is down 2.5% over 12 months.
Let's start the week with some new ratings from market experts (courtesy The Bull).
Image source: Getty Images
JB Hi Fi Ltd (ASX: JBH)
The JB Hi-Fi share price has tumbled 37% over 12 months.
Andrew Wielandt from DP Wealth Advisory has a buy call on this ASX 200 consumer discretionary share.
Wielandt said:
This consumer electronics giant continues to show why it's one of Australia's highest quality retailers.
The company delivered record total sales of $11.06 billion in full year 2026, up 4.8 per cent on the prior corresponding period.
Net profit after tax of $489.9 million increased 6 per cent. The total fully franked dividend of $3.37 was up 22.5 per cent.
The company continues to take market share through its low cost operating model, strong brand recognition and leadership across consumer electronics.
Our recommendation is supported by a proven management team, strong cash generation and a history of executing well during varying economic conditions.
Sandfire Resources Ltd (ASX: SFR)
The Sandfire Resources share price is up 31% over 12 months.
Michael Gable from Fairmont Equities has a hold rating on this ASX 200 copper share.
Gable said:
SFR is Australia's largest listed pure play copper producer. Copper demand is increasing in an environment of low supply and this is likely to lead to higher prices.
Group sales revenue of $1.7 billion in full year 2026 was up 41 per cent year on year. Profit after tax of $354 million was up 294 per cent.
Its final fully franked dividend of 35 cents a share was much higher than the market was expecting.
From a charting perspective, the price action for SFR looks bullish and we expect to see a sustainable uptrend from here.
Ramsay Health Care Ltd (ASX: RHC)
The Ramsay Health Care share price has streaked 77% higher over 12 months.
Toby Grimm from Baker Young has a sell rating on this ASX 200 healthcare share.
Grimm explained:
Ramsay Health Care is one of the largest private hospital operators in Australia. It has additional operations in the UK and Europe.
Ramsay's operations have improved. Insurer pricing better reflects cost inflation, with higher demand and higher margin procedures prioritised.
Yet the industry remains challenging and public sector competitors effectively set input costs without needing to operate profitably.
The stock has strongly rallied in the past 12 months to the point we believe it's exposed to a pullback.
The forward price/earnings ratio has risen significantly above its 10-year average.
Investors may want to consider booking profits and monitor performance from the sidelines.
